Podcast Episodes

Back to Search
HPQ Silicon Nano Reactor Ready To Produce Samples For 3rd Party Evaluation Imminently
HPQ Silicon Nano Reactor Ready To Produce Samples For 3rd Party Evaluation Imminently

Season 3 Episode 207

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing high value-added silicon products that are sought after by battery and…

4 years, 10 months ago

Short Long
View Episode
Logiq Hits Record Quarter At $12.3M Preliminary Revenues. Expects $48M Before M&A And Spinout Of South East Asia Tech In 2022
Logiq Hits Record Quarter At $12.3M Preliminary Revenues. Expects $48M Before M&A And Spinout Of South East Asia Tech In 2022

Season 3 Episode 206

The global e-commerce market surpassed $9 TRILLION in 2019 … and is scheduled to grow by a CAGR of 14% into 2027 … But mega brands control almost 70%…

4 years, 10 months ago

Short Long
View Episode
Valeo Pharma Immune Booster Now Available In ~300 Stores Under Loblaws Banner, Another Step Closer to 2025 Revenue Target of $160M
Valeo Pharma Immune Booster Now Available In ~300 Stores Under Loblaws Banner, Another Step Closer to 2025 Revenue Target of $160M

Season 3 Episode 205

Valeo Pharma is already a successful, revenue-generating, small-cap Canadian pharmaceutical company that acquires the Canadian rights to commercializ…

4 years, 10 months ago

Short Long
View Episode
Liquid Avatar Metaverse Sales Hit $1,000,000 In Preliminary Gross Revenue - Setting Up Big 2022 and Potential Token Offering
Liquid Avatar Metaverse Sales Hit $1,000,000 In Preliminary Gross Revenue - Setting Up Big 2022 and Potential Token Offering

Season 3 Episode 204

The genesis of Liquid Avatar Technologies is a global blockchain & personal identity solutions company specializing in empowering individuals to mana…

4 years, 10 months ago

Short Long
View Episode
Empower Clinics Starts 2022 With Major Press Releases Foreshadowing An Emerging Healthcare Behemoth
Empower Clinics Starts 2022 With Major Press Releases Foreshadowing An Emerging Healthcare Behemoth

Season 3 Episode 203

While most companies and investors are relaxing on New Years Eve and just getting organized on the first trading day of the year, Empower Clinics $CB…

4 years, 10 months ago

Short Long
View Episode
NOW is a Big Data, Vertical Intelligence Software and Services Company Addressing A $150-$200 Billion Market
NOW is a Big Data, Vertical Intelligence Software and Services Company Addressing A $150-$200 Billion Market

Season 3 Episode 203

The Big data market is ~ $150/200 Billion and growing at torrid pace for obvious reasons.

NOW is a Big Data, Vertical Intelligence (VI) software and …

4 years, 10 months ago

Short Long
View Episode
Fobi AI Year In Review – A Must See 1-Hour Jam Session
Fobi AI Year In Review – A Must See 1-Hour Jam Session

Season 3 Episode 202

FOBI AI is a global leader in digital wallet pass technology that delivers real-time data analytics and engagement through artificial intelligence to…

4 years, 10 months ago

Short Long
View Episode
Forward Water Technologies Patented Forward Osmosis Tech Can Reduce Water Consumption By As Much As 90% In Many Industrial Applications
Forward Water Technologies Patented Forward Osmosis Tech Can Reduce Water Consumption By As Much As 90% In Many Industrial Applications

Season 3 Episode 201

The global water and wastewater treatment market is projected to grow from $283.48 billion in 2021 to $465.23 billion in 2028 at a CAGR of 7.3%.

WHY?…

4 years, 10 months ago

Short Long
View Episode
Solvbl Solutions Proprietary Tech Operates Dramatically Faster and At Lower Latency Than Blockchain
Solvbl Solutions Proprietary Tech Operates Dramatically Faster and At Lower Latency Than Blockchain

Season 3 Episode 200

It’s no secret that we live in a digital data age. Data is critical for the present and future of automation, AI, IoT, analytics etc. As decisions be…

4 years, 10 months ago

Short Long
View Episode
Valeo Pharma Obtains Public Reimbursement For Asthma Drugs In Quebec and Nova Scotia, Another Step Closer to 2025 Revenue Target of $160M
Valeo Pharma Obtains Public Reimbursement For Asthma Drugs In Quebec and Nova Scotia, Another Step Closer to 2025 Revenue Target of $160M

Season 3 Episode 199

Valeo Pharma is already a successful, revenue-generating, small-cap Canadian pharmaceutical company that acquires the Canadian rights to commercializ…

4 years, 11 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us